Explore more publications!
Health Update Bahamas
Got News to Share?

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 19, 2025

Tevogen CEO Donates Personal Shares to Support Local Fire Department
December 19, 2025

Tevogen CEO Donates Personal Shares to Support Local Fire Department

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
December 19, 2025

Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman

Indeterminate GlobeNewswire
OncoInv and MaxBloch Partner to Expand Early Cancer Detection Across Central America
December 19, 2025

OncoInv and MaxBloch Partner to Expand Early Cancer Detection Across Central America

Indeterminate GlobeNewswire
OncoInv y MaxBloch se asocian para ampliar la detección temprana de cáncer en Centroamérica
December 19, 2025

OncoInv y MaxBloch se asocian para ampliar la detección temprana de cáncer en Centroamérica

Indeterminate GlobeNewswire
OncoInv e MaxBloch firmam parceria para expandir a detecção precoce do câncer em toda a América Central
December 19, 2025

OncoInv e MaxBloch firmam parceria para expandir a detecção precoce do câncer em toda a América Central

Indeterminate GlobeNewswire
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
December 19, 2025

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

Indeterminate GlobeNewswire
NRPA Releases 2025 Engagement With Parks Report Highlighting Continued Public Demand
December 19, 2025

NRPA Releases 2025 Engagement With Parks Report Highlighting Continued Public Demand

Indeterminate GlobeNewswire
Cannabix Technologies Launches New Marijuana Breath Test Product Videos as U.S. Cannabis Reclassification Underscores the Urgent Need for Innovative Public Safety Solutions
December 19, 2025

Cannabix Technologies Launches New Marijuana Breath Test Product Videos as U.S. Cannabis Reclassification Underscores the Urgent Need for Innovative Public Safety Solutions

Indeterminate GlobeNewswire
Bobby Rahal Automotive Group Donates $35,000 to SoldierStrong to Support Military Veterans in Taking Their Next Steps Forward
December 19, 2025

Bobby Rahal Automotive Group Donates $35,000 to SoldierStrong to Support Military Veterans in Taking Their Next Steps Forward

Indeterminate GlobeNewswire
EMJX Enhances Gen2 Digital Asset Treasury Operating System On OpenAI’s Large Language Models (LLMs) for Research and Risk Decision Support
December 19, 2025

EMJX Enhances Gen2 Digital Asset Treasury Operating System On OpenAI’s Large Language Models (LLMs) for Research and Risk Decision Support

Indeterminate GlobeNewswire
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro
December 19, 2025

MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro

Indeterminate GlobeNewswire
Jyong Biotech Responds to Share Price and Volume Movement
December 19, 2025

Jyong Biotech Responds to Share Price and Volume Movement

Indeterminate GlobeNewswire
Remedy's Nutrition® Launches Mega VMT™ High-Potency Multivitamin to Revolutionize Daily Energy and Nutritional Wellness
December 19, 2025

Remedy's Nutrition® Launches Mega VMT™ High-Potency Multivitamin to Revolutionize Daily Energy and Nutritional Wellness

Indeterminate GlobeNewswire
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
December 19, 2025

Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

Indeterminate GlobeNewswire
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
December 19, 2025

Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience

Indeterminate GlobeNewswire
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals
December 19, 2025

NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals

Indeterminate GlobeNewswire
Sienna Completes Acquisition in the Greater Toronto Area
December 19, 2025

Sienna Completes Acquisition in the Greater Toronto Area

Indeterminate GlobeNewswire
Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses
December 19, 2025

Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses

Indeterminate GlobeNewswire
Outlook Therapeutics Reports Financial Results for Fiscal Year 2025
December 19, 2025

Outlook Therapeutics Reports Financial Results for Fiscal Year 2025

Indeterminate GlobeNewswire
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
December 19, 2025

Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions